Copyright
©2010 Baishideng.
World J Gastroenterol. Jan 14, 2010; 16(2): 143-155
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.143
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.143
Local risk factors for PVT (70%) |
Cancer |
Any abdominal organ |
Focal inflammatory lesions |
Neonatal omphalitis, ombilical vein catheterization |
Diverticulitis, appendicitis |
Pancreatitis |
Duodenal ulcer |
Cholecystitis |
Tuberculous lymphadenitis |
Crohn’s disease, ulcerative colitis |
Cytomegalovirus hepatitis |
Injury to the portal venous system |
Splenectomy |
Colectomy, gastrectomy |
Cholecystectomy |
Liver transplantation |
Abdominal trauma |
Surgical portosystemic shunting, TIPS |
Iatrogenic (fine needle aspiration of abdominal masses etc.) |
Cirrhosis |
Preserved liver function with precipitating factors (splenectomy, surgical portosystemic shunting, TIPS dysfunction, thrombophilia) |
Advanced disease in the absence of obvious precipitating factors |
Systemic risk factors for PVT (30%) |
Inherited |
Factor V Leiden mutation |
Factor II (prothrombin) mutation |
Protein C deficiency |
Protein S deficiency |
Antithrombin deficiency |
Acquired |
Myeloproliferative disorder |
Antiphospholipid syndrome |
Paroxysmal nocturnal hemoglobinuria |
Oral contraceptives |
Pregnancy or puerperium |
Hyperhomocysteinemia |
Malignancy |
Table 3 Prevalence of thrombotic risk factors in series of routinely investigated, consecutive adult patients with non tumorous and non cirrhotic, acute or chronic, PVT[126]
Risk factor | PVT patients (%) |
Myeloproliferative disorders | 30-40 |
Atypical | 14 |
Classical | 17 |
Antithrombin deficiency | 0-26 |
Protein C deficiency | 0-26 |
Protein S deficiency | 2-30 |
Factor V Leiden mutation | 6-32 |
Prothrombine mutation | 14-40 |
TT677 methylene tetrahydrofolate reductase (MTHFR) genotype | 11-50 |
Antiphospholipid syndrome | 6-19 |
Hyperomocisteinemia | 12-22 |
Recent pregnancy | 6-40 |
Recent oral contraceptive use | 12 |
Table 4 AASLD recommendations for diagnosis of acute and chronic PVT[126]
AASLD recommendations for diagnosis of acute PVT | AASLD recommendations for diagnosis of chronic PVT |
Consider a diagnosis of acute PVT in any patient with abdominal pain of more than 24 h duration, whether or not there is also fever or ileus | Consider a diagnosis of chronic PVT in any patient with newly diagnosed portal hypertension |
If acute PVT is suspected, computed tomography (CT) scan, before and after injection of vascular contrast agent, should be obtained for early confirmation of diagnosis. If CT scan is not rapidly available, obtain Doppler-sonography | Obtain Doppler-sonography, then either CT scan or MRI, before and after a vascular contrast agent, to make a diagnosis of chronic PVT |
In patients with acute PVT and high fever, septic pylephlebitis should be considered, whether or not an abdominal source of infection has been identified, and blood cultures should be routinely obtained | Base the diagnosis on the absence of a visible normal portal vein and its replacement with serpiginous veins |
In acute PVT, the possibility of intestinal infarction should be considered from presentation until resolution of pain. The presence of ascites, thinning of the intestinal wall, lack of mucosal enhancement of the thickened intestinal wall, or the development of multiorgan failure indicate that intestinal infarction is likely and surgical exploration should be considered |
Table 5 Intraoperatory grading of PVT extension[17]
Yerdel’s grading |
< 50% occlusion of the portal vein |
> 50% occlusion of the portal vein (including total occlusion) |
Complete thrombosis of both portal and proximal superior mesenteric vein |
Complete thrombosis of portal vein and proximal and distal superior mesenteric vein |
- Citation: Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Maurizio LD, Bombardieri G, Cristofaro RD, Gaetano AMD, Landolfi R, Gasbarrini A. Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16(2): 143-155
- URL: https://www.wjgnet.com/1007-9327/full/v16/i2/143.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i2.143